BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22209712)

  • 1. Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.
    Connolly S; Skrinjar M; Rosendahl A
    Biochem Pharmacol; 2012 Mar; 83(6):778-87. PubMed ID: 22209712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration.
    Karlsson AK; Walles K; Bladh H; Connolly S; Skrinjar M; Rosendahl A
    Biochem Biophys Res Commun; 2011 Apr; 407(4):764-71. PubMed ID: 21439940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthma.
    Wang L; Jenkins TJ; Dai M; Yin W; Pulido JC; Lamantia-Martin E; Hodge MR; Ocain T; Kolbeck R
    Thorax; 2013 Jun; 68(6):506-12. PubMed ID: 23457038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
    Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
    J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
    Rummel PC; Arfelt KN; Baumann L; Jenkins TJ; Thiele S; Lüttichau HR; Johnsen A; Pease J; Ghosh S; Kolbeck R; Rosenkilde MM
    Br J Pharmacol; 2012 Nov; 167(6):1206-17. PubMed ID: 22708643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
    Goya I; Gutiérrez J; Varona R; Kremer L; Zaballos A; Márquez G
    J Immunol; 1998 Feb; 160(4):1975-81. PubMed ID: 9469461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.
    Jensen PC; Nygaard R; Thiele S; Elder A; Zhu G; Kolbeck R; Ghosh S; Schwartz TW; Rosenkilde MM
    Mol Pharmacol; 2007 Aug; 72(2):327-40. PubMed ID: 17652183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309.
    Colantonio L; Iellem A; Sinigaglia F; D'Ambrosio D
    Eur J Immunol; 2002 Dec; 32(12):3506-14. PubMed ID: 12442333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
    Das S; Sarrou E; Podgrabinska S; Cassella M; Mungamuri SK; Feirt N; Gordon R; Nagi CS; Wang Y; Entenberg D; Condeelis J; Skobe M
    J Exp Med; 2013 Jul; 210(8):1509-28. PubMed ID: 23878309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
    Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
    J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
    Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
    Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites.
    Shamovsky I; de Graaf C; Alderin L; Bengtsson M; Bladh H; Börjesson L; Connolly S; Dyke HJ; van den Heuvel M; Johansson H; Josefsson BG; Kristoffersson A; Linnanen T; Lisius A; Männikkö R; Nordén B; Price S; Ripa L; Rognan D; Rosendahl A; Skrinjar M; Urbahns K
    J Med Chem; 2009 Dec; 52(23):7706-23. PubMed ID: 19954248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.
    Oshio T; Kawashima R; Kawamura YI; Hagiwara T; Mizutani N; Okada T; Otsubo T; Inagaki-Ohara K; Matsukawa A; Haga T; Kakuta S; Iwakura Y; Hosokawa S; Dohi T
    PLoS One; 2014; 9(4):e94445. PubMed ID: 24714157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
    Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of RNA aptamers that block CCL1 chemokine function.
    Marro ML; Daniels DA; Andrew DP; Chapman TD; Gearing KL
    Biochem Biophys Res Commun; 2006 Oct; 349(1):270-6. PubMed ID: 16930539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
    Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
    J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics.
    Panina-Bordignon P; Papi A; Mariani M; Di Lucia P; Casoni G; Bellettato C; Buonsanti C; Miotto D; Mapp C; Villa A; Arrigoni G; Fabbri LM; Sinigaglia F
    J Clin Invest; 2001 Jun; 107(11):1357-64. PubMed ID: 11390417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.